Sodium Chloride 0.9% w/v Solution for Infusion Irska - engleski - HPRA (Health Products Regulatory Authority)

sodium chloride 0.9% w/v solution for infusion

fresenius kabi deutschland gmbh - sodium chloride - solution for infusion - 0.9 percent weight/volume - sodium chloride

Sodium Chloride 0.9% w/v Solution for Infusion Irska - engleski - HPRA (Health Products Regulatory Authority)

sodium chloride 0.9% w/v solution for infusion

fresenius kabi deutschland gmbh - sodium chloride - solution for infusion - 0.9 percent weight/volume - sodium chloride

Sodium Chloride 0.9%w/v Solution for Infusion Irska - engleski - HPRA (Health Products Regulatory Authority)

sodium chloride 0.9%w/v solution for infusion

fresenius kabi deutschland gmbh - sodium chloride - solution for infusion - 0.9 percent weight/volume - sodium chloride

Sodium Chloride Novi Zeland - engleski - Medsafe (Medicines Safety Authority)

sodium chloride

baxter healthcare ltd - sodium chloride 0.45% - solution for infusion - 0.45 % - active: sodium chloride 0.45% - hypotonic sodium chloride (0.45%) intravenous infusion is mainly used as a hydrating agent solution.

Sodium Chloride Novi Zeland - engleski - Medsafe (Medicines Safety Authority)

sodium chloride

baxter healthcare ltd - sodium chloride 3% - solution for infusion - 3 % - active: sodium chloride 3% - hypertonic sodium chloride (3%) intravenous infusion is used in the management of severe sodium chloride depletion when electrolyte restoration is required.

Sodium Chloride 0.9 % w/v and Glucose 5% w/v Solution for Infusion BP (Viaflo container) Irska - engleski - HPRA (Health Products Regulatory Authority)

sodium chloride 0.9 % w/v and glucose 5% w/v solution for infusion bp (viaflo container)

baxter healthcare limited - sodium chloride; sodium chloride; glucose monohydrate; glucose monohydrate - solution for infusion - 0.9/5 %w/v percent weight/volume - salt solutions; sodium chloride

Potassium Chloride 0.15% w/v & Sodium Chloride 0.9% w/v Solution for Infusion Irska - engleski - HPRA (Health Products Regulatory Authority)

potassium chloride 0.15% w/v & sodium chloride 0.9% w/v solution for infusion

fresenius kabi limited - potassium chloride; sodium chloride - solution for infusion - 0.15% w/v + 0.9% w/v percent weight/volume - solutions affecting the electrolyte balance; electrolytes

Potassium Chloride 0.3% w/v & Sodium Chloride 0.9% w/v Solution for Infusion Irska - engleski - HPRA (Health Products Regulatory Authority)

potassium chloride 0.3% w/v & sodium chloride 0.9% w/v solution for infusion

fresenius kabi limited - potassium chloride; sodium chloride - solution for infusion - 0.3% w/v + 0.9% w/v percent weight/volume - solutions affecting the electrolyte balance; electrolytes

BAXTER POTASSIUM CHLORIDE 40 mmol and 0.9% SODIUM CHLORIDE 1000 mL intravenous infusion bag Australija - engleski - Department of Health (Therapeutic Goods Administration)

baxter potassium chloride 40 mmol and 0.9% sodium chloride 1000 ml intravenous infusion bag

baxter healthcare pty ltd - potassium chloride, quantity: 2.98 g/l; sodium chloride, quantity: 9 g/l - injection, intravenous infusion - excipient ingredients: water for injections; hydrochloric acid - the baxter potassium chloride and sodium chloride intravenous infusion is indicated as a source of water and to restore electrolyte balance as required by the patient's clinical condition, such as hypokalaemia.

NICARDIPINE HYDROCHLORIDE capsule Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

nicardipine hydrochloride capsule

epic pharma, llc - nicardipine hydrochloride (unii: k5bc5011k3) (nicardipine - unii:cz5312222s) - nicardipine hydrochloride 20 mg - nicardipine hydrochloride capsules are indicated for the management of patients with chronic stable angina (effort-associated angina). nicardipine hydrochloride capsules may be used alone or in combination with beta-blockers. nicardipine hydrochloride capsules are indicated for the treatment of hypertension. nicardipine hydrochloride capsules may be used alone or in combination with other antihypertensive drugs. in administering nicardipine hydrochloride it is important to be aware of the relatively large peak to trough differences in blood pressure effect (see dosage and administration). nicardipine hydrochloride capsules are contraindicated in patients with hypersensitivity to the drug. because part of the effect of nicardipine hydrochloride capsules are secondary to reduced afterload, the drug is also contraindicated in patients with advanced aortic stenosis. reduction of diastolic pressure in these patients may worsen rather than improve myocardial oxygen balance.